Aardvark Therapeutics (AARD) closed at $1.30 on October 27, 2026, up 20.4% from the previous close, on volume of 4,164,043 shares (30-day average 864,974).
Data as of October 27, 2026.
Market Chameleon (Tue, 27-Oct 6:28 AM ET)
Globe Newswire (Mon, 26-Oct 8:51 AM ET)
TipRanks (Sun, 25-Oct 8:30 PM ET)
Aardvark Therapeutics advances ARD-101 after FDA hold lift
TipRanks (Fri, 23-Oct 9:28 AM ET)
Globe Newswire (Fri, 23-Oct 7:00 AM ET)
TipRanks (Fri, 23-Oct 6:35 AM ET)
FDA Lifts Clinical Hold on Aardvark’s ARD-101 Program
TipRanks (Thu, 22-Oct 4:52 PM ET)
Globe Newswire (Thu, 22-Oct 4:05 PM ET)
Globe Newswire (Wed, 21-Oct 8:24 AM ET)
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Aardvark Therapeutics trades on the NASDAQ stock market under the symbol AARD.
As of October 27, 2026, AARD stock price climbed to $1.30 with 4,164,043 million shares trading.
AARD has a beta of 4.70, meaning it tends to be more sensitive to market movements. AARD has a correlation of 0.14 to the broad based SPY ETF.
AARD has a market cap of $28.45 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that AARD belongs to (by Net Assets): VTI, VXF, IBB, IWC, BUSM.
AARD has underperformed the market in the last year with a price return of -87.9% while the SPY ETF gained +14.8%. AARD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -79.4% and -70.8%, respectively, while the SPY returned +4.4% and -1.1%, respectively.
AARD support price is $.98 and resistance is $1.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AARD shares will trade within this expected range on the day.
